JET 7 Xtra Flex Catheter Recall Attorneys

Are you a stroke patient that has undergone a medical procedure that used a Penumbra JET 7 Xtra Flex Catheter that resulted in serious injury?

If so, Lerner and Rowe is now accepting individual injury claims to review from stroke patients, or families members of deceased patients, who were harmed when using the recalled devices to remove a blood clot. 

Our dedicated defective product attorneys invite you to contact us for a free JET 7 Xtra Flex catheter case evaluation to help determine if you are eligible for financial compensation or other damages. 

Urgent JET 7 Xtra FlexRecall Issued byPenumbra

In December 2020, the U.S. Food and Drug Administration (FDA) announced that Penumbra, Inc. recalled all Penumbra Reperfusion Catheters with Xtra Flex Technology (Jet 7 Xtra Flex). The product recall was issued because of an increased risk of injury and death in stroke patients during procedures to remove blood clots.  Health care providers have been informed not to use the JET 7 Xtra Flex catheter, to remove and quarantine all unused affected products in your inventory, and to return the affected products to Penumbra in accordance with Penumbra’s instructions. 

The affected devices listed include all configurations of the following:

  • JET 7 Xtra Flex catheter, originally cleared under K190010 on June 16, 2019.
  • JET 7MAX configuration (which includes the JET 7 Xtra Flex catheter and MAX Delivery Device) cleared under K191946 on February 27, 2020.

Free Case Evaluation

Reported Injuries Caused by Defective JET 7 Xtra Flex Catheters 

The FDA received more than 200 medical device reports (MDRs) about device malfunctions to include “ballooning, expansion, rupture, breakage or complete separation, and exposure of internal support coils near the distal tip region of the JET 7 Xtra Flex catheter.”

When an expansion occurred, it caused the blood vessel to rupture resulting in serious complications and injuries. Some surgeons have also alleged that while they attempted to remove blood clots from stroke patients’ brains, the catheter would occasionally break or fray. This product defect would cost precious minutes during a critical point in a surgery to fix the fracture.

Serious injuries reported to the FDA included:

  • Cerebral infarction
  • Death
  • Hemorrhages
  • Hemorrhagic stroke
  • Vessel damage

How Lerner and Rowe Helps Individuals Harmed by JET 7 Xtra Flex Device

If you, or a loved one, experienced a negative reaction after a surgery using a JET 7 Xtra Flex to treat a blood clot, we want to hear from you. 

Our Jet 7 recall attorneys are here to help you hold Penumbra responsible for being harmed by this defective device and to collect any compensation that you may be entitled to for medical expenses, lost wages, and other costs and damages. 

During your free consultation, our legal team will explain the next steps if you qualify to file a lawsuit against Penumbra. This manufacturer should be held accountable for any defective products that caused harm to others. 

At Lerner and Rowe Injury Attorneys, we have helped thousands of injured clients seek compensation for others negligent actions. In 2019 alone, our legal team recovered over $200 million. Contact us 24/7 to learn more about how we can assist you. Call 844-977-1900, use our LiveChat feature, or submit an online review form now. 

We are here to help alleviate any confusion you may have regarding your legal options regarding a defective JET 7 Xtra Flex catheter